Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Kcas Bioanalytical And Biomarker Services 401(K) Plan is a benefit plan reported by Integris Bioservices, LLC under EIN 83-2388558 and plan number 001. The latest loaded filing year is 2023. The filing reports 376 participants and $15,416,536 in end-of-year plan assets, where available in the loaded dataset.
Reported financial statement (2023 · Schedule H)
Net assets
- Total assets (EOY)
- $15,416,536
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $15,416,536
- Net assets (BOY)
- $11,993,804
Income & contributions
- Employer contributions
- $1,005,548
- Participant contributions
- $1,991,190
- Total contributions
- $3,506,655
- Total income / additions
- $5,765,519
Expenses & distributions
- Benefits paid
- $2,299,173
- Administrative expenses
- $41,220
- Total expenses
- $2,342,787
- Net increase / (decrease)
- $3,422,732